Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.Share:More In Business Bristol Myers Squibb to Buy Koruna Therapeutics for $14 BillionBristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.No more stories
Bristol Myers Squibb to Buy Koruna Therapeutics for $14 BillionBristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.